MARK W SMITS Insider Trading
Get free email notifications about insider trading for MARK W SMITS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MARK W SMITS. MARK W SMITS is a SVP-Commercial Operations in QUIDEL CORP /DE/ ($QDEL) and a Chief Commercial Officer in NEOGENOMICS INC ($NEO).
Address: C/O NEOGENOMICS, INC. 12701 COMMONWEALTH DRIVE SUITE 9 FORT MYERS US 33913 FL
Companies in which MARK W SMITS is an Insider
NEOGENOMICS INC
Trading Symbol: NEOIndustry: SERVICES-TESTING LABORATORIES [8734]
Position of MARK W SMITS: Chief Commercial Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 20 2011
$NEO Market Capitalization: $625.74M
$NEO Previous Close: $8.04
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
QUIDEL CORP /DE/
Trading Symbol: QDELIndustry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of MARK W SMITS: SVP-Commercial Operations
Holdings: 9,608 shares
Current Value: $190,911
Latest Transaction: Jun 02 2015
$QDEL Market Capitalization: $640.78M
$QDEL Previous Close: $19.87
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of MARK W SMITS
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 02 2015 | QDEL | QUIDEL CORP /DE/ | SMITS MARK W | SVP-Commercial Oper ... | Payment of Exercise | F | 21.97 | 2,497 | 54,859 | 9,608 | 12.1 K to 9.6 K (-20.63 %) |
Jun 02 2015 | QDEL | QUIDEL CORP /DE/ | SMITS MARK W | SVP-Commercial Oper ... | Grant | A | 0.00 | 9,136 | 0 | 12,105 | 3 K to 12.1 K (+307.71 %) |
Mar 04 2015 | QDEL | QUIDEL CORP /DE/ | SMITS MARK W | SVP-Commercial Oper ... | Payment of Exercise | F | 26.41 | 439 | 11,594 | 2,969 | 3.4 K to 3 K (-12.88 %) |
Mar 04 2015 | QDEL | QUIDEL CORP /DE/ | SMITS MARK W | SVP-Commercial Oper ... | Grant | A | 0.00 | 1,635 | 0 | 3,408 | 1.8 K to 3.4 K (+92.22 %) |
Feb 27 2015 | QDEL | QUIDEL CORP /DE/ | SMITS MARK W | SVP-Commercial Oper ... | Payment of Exercise | F | 25.68 | 208 | 5,341 | 1,773 | 2 K to 1.8 K (-10.50 %) |
Feb 27 2015 | QDEL | QUIDEL CORP /DE/ | SMITS MARK W | SVP-Commercial Oper ... | Grant | A | 0.01 | 788 | 8 | 1,981 | 1.2 K to 2 K (+66.05 %) |
May 20 2011 | NEO | NEOGENOMICS INC | SMITS MARK W | Chief Commercial Of ... | Option Exercise | M | 1.02 | 45,000 | 45,900 | 0 |